title: Psychiatric issues in pulmonary disease.
abstract: This article has attempted to provide an overview of the clinical literature regarding the psychological issues facing patients with pulmonary disease, depending on when the illness begins in the life span, because different developmental tasks are disrupted. Patients must contend with side effects of medication that may mimic or exacerbate psychiatric disorders. The main drug interactions for psychiatrists to be aware of in this patient population occur between rifampin, or theophylline and psychotropic medications. In lung transplant recipients on cyclosporine therapy, the antidepressant drug nefazadone may cause increased cyclosporine levels. Psychiatrists must be aware of the risks, benefits, and survival statistics; educate patients; and ascertain whether the patient is competent to make medical decisions regarding treatment procedures.
authors.affiliation: Department of Psychiatry, Comprehensive Liver Disease Center, St. Vincent Medical Center, Los Angeles, California, USA. ChristinaT@CHW.edu
authors.forename: Kathy
authors.initials: K
authors.lastname: Coffman
mesh_terms: D004347:Drug Interactions; D006801:Humans; D008171:Lung Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology*; D001523:Mental Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology*; D010348:Patient Care Team; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000009:adverse effects; D012803:Sick Role
chemical_list: D011619:Psychotropic Drugs